AZ Central20d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Death is imminent," Wright said. Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi.
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
Reuters13d
$35 insulin: Who in the US benefits?
A Lilly spokesperson said there are currently over 50,000 Lispro prescriptions filled weekly at U.S. pharmacies which can get ...
Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
USA Today20d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi. Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply. Novo Nordisk ...
USA Today20d
As insulin shortages persist, what diabetes patients can do
Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter ... are approved to treat weight loss. Drug companies have invested hundreds of millions ...
The Indianapolis Star20d
As insulin shortages persist, what diabetes patients can do
Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter ... reported shortages of NovoLog insulin. Drug companies recommend patients check with ...